Source: International Mining
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Between January 2, 2023, and January 1, 2024, Osisko may acquire up to 29,053,640 common shares
  • Daily purchases will be limited to 126,972 common shares
  • The company believes that the bid will be advantageous to all shareholders.
  • During the current bid, which will end on January 1, 2023, Osisko purchased 5,852,665 common shares at an average price of $3.97 per share
  • Osisko is a mineral exploration company focused on the exploration and development of precious metal resource properties in Canada
  • Osisko Mining Inc. (OSK) opened trading at C$3.42

Osisko Mining (OSK) is renewing its normal course issuer bid.

Under the bid, Osisko may acquire up to 29,053,640, or 10 per cent of the company’s public float of common shares, between January 2, 2023, and January 1, 2024.

Daily purchases will be limited to 126,972 common shares, representing 25 per cent of the average daily trading volume on the TSX for the six-month period ending November 30, 2022.

The company believes that the bid will be advantageous to all shareholders.

During the current bid, which will end on January 1, 2023, Osisko purchased 5,852,665 common shares at an average price of $3.97 per share.

Osisko has appointed BMO Nesbitt Burns Inc. to make any purchases under the NCIB Program on its behalf.

Osisko is a mineral exploration company focused on the exploration and development of precious metal resource properties in Canada. Osisko holds a 100 per cent interest in the high-grade Windfall gold deposit in Québec and holds a 100 per cent undivided interest in a large area of claims in the surrounding Urban Barry area and nearby Quévillon area.

Osisko Mining Inc. (OSK) opened trading at C$3.42.


More From The Market Herald

@ the Bell: Little movement among markets

The TSX stock index kept on the positive side Tuesday as global risk-off sentiments weighed ahead of more economic data later this week.

Clearmind posts results from weight loss pre-clinical trial

Clearmind Medicine (CSE:CMND) has revealed positive results from its weight loss pre-clinical trial in animal subjects.

Great Atlantic Resources completes 2023 program at South Quarry

Great Atlantic Resources has completed its 2023 exploration program at its 100-per-cent-owned South Quarry tungsten property in Newfoundland.

Mispriced oil stock continues to add premium drilling locations

Nexera Energy, a mispriced oil stock, has increased its ownership in the Marpat leases in Bexar County, Texas, from 25 to 100 per cent.